Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaginal Yeast Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03930745
What this trial is testing

Suppression Of Bacterial Vaginosis (BV) [SUBVert]

Who this might be right for
Bacterial Vaginosis
National Institute of Allergy and Infectious Diseases (NIAID) 81
Early research (Phase 1)Study completedNCT01067131
What this trial is testing

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Pevion Biotech Ltd 48
Large-scale testing (Phase 3)Study completedNCT05399641
What this trial is testing

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Who this might be right for
Vulvovaginal Candidiasis
Scynexis, Inc. 150
Not applicableLooking for participantsNCT05908682
What this trial is testing

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

Who this might be right for
Vulvovaginitis, CandidalVulvovaginal CandidiasisCandida Infection+1 more
GlaxoSmithKline 100
Not applicableEnded earlyNCT01915251
What this trial is testing

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Who this might be right for
MicrobiomeAntibiotic-Induced VVCVaginal Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 13
Not applicableStudy completedNCT06572488
What this trial is testing

Non-ablative Er:YAG for Recurrent Candidiasis

Who this might be right for
Candidiasis, VulvovaginalCandidiasis of VaginaCandidiasis, Genital+3 more
Espacio Gaspar Clinic 167
Testing effectiveness (Phase 2)Study completedNCT03372395
What this trial is testing

Probiotic Implementation as Help in Solving Vaginal Infections

Who this might be right for
Vaginal InfectionASC-US
University of Roma La Sapienza 117
Not applicableActive Not RecruitingNCT05079711
What this trial is testing

Comparative Performance of a Vaginal Yeast Test

Who this might be right for
Vulvovaginal Candidiasis
Uniformed Services University of the Health Sciences 1,200
Not applicableStudy completedNCT03761628
What this trial is testing

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Who this might be right for
Vulvovaginal Candidiasis
Gedea Biotech AB 24
Testing effectiveness (Phase 2)Study completedNCT02733432
What this trial is testing

RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Who this might be right for
Candidiasis, VulvovaginalMycosesYeast Infection+2 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 126
Large-scale testing (Phase 3)Study completedNCT03987620
What this trial is testing

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

Who this might be right for
Candida Vulvovaginitis
Scynexis, Inc. 455
Testing effectiveness (Phase 2)WithdrawnNCT03167957
What this trial is testing

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

Who this might be right for
Vulvovaginal CandidiasesYeast InfectionVulvovaginitis+2 more
Matinas BioPharma Nanotechnologies, Inc.
Large-scale testing (Phase 3)Study completedNCT03561701
What this trial is testing

Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 425
Large-scale testing (Phase 3)Study completedNCT03840616
What this trial is testing

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 219
Testing effectiveness (Phase 2)Study completedNCT02267382
What this trial is testing

Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Viamet 254